| scholarly article | Q13442814 |
| P50 | author | Christopher Burlak | Q91424248 |
| A Joseph Tector | Q104720732 | ||
| P2093 | author name string | Ping Li | |
| Zheng-Yu Wang | |||
| Ray K Chihara | |||
| Luz M Reyes | |||
| Richard A Sidner | |||
| Andrew J Lutz | |||
| Fuqin Yin | |||
| Jose L Estrada | |||
| Leela L Paris | |||
| Susan M Downey | |||
| Ross L Blankenship | |||
| Bess Ivary | |||
| P2860 | cites work | Functionally important glycosyltransferase gain and loss during catarrhine primate emergence | Q28763873 |
| Efficient generation of a biallelic knockout in pigs using zinc-finger nucleases | Q29042244 | ||
| Production of alpha-1,3-galactosyltransferase null pigs by means of nuclear transfer with fibroblasts bearing loss of heterozygosity mutations | Q33904933 | ||
| Production of alpha 1,3-galactosyltransferase-deficient pigs | Q33963251 | ||
| Acute rejection is associated with antibodies to non-Gal antigens in baboons using Gal-knockout pig kidneys | Q34480315 | ||
| Human-specific evolution of sialic acid targets: explaining the malignant malaria mystery? | Q37329601 | ||
| Complement regulation in the GalT KO era. | Q37690881 | ||
| Genetic engineering including superseding microinjection: new ways to make GM pigs | Q37821065 | ||
| Cell Biology Symposium: Zinc finger nucleases to create custom-designed modifications in the swine (Sus scrofa) genome. | Q37950979 | ||
| Isolation, Characterization, and Nuclear Reprogramming of Cell Lines Derived from Porcine Adult Liver and Fat | Q39645806 | ||
| Targeted disruption of the alpha1,3-galactosyltransferase gene in cloned pigs | Q40747307 | ||
| Cloning and functional characterization of pig CMP-N-acetylneuraminic acid hydroxylase for the synthesis of N-glycolylneuraminic acid as the xenoantigenic determinant in pig-human xenotransplantation | Q42644661 | ||
| Deficiency of N-glycolylneuraminic acid and Galα1-3Galβ1-4GlcNAc epitopes in xenogeneic cells attenuates cytotoxicity of human natural antibodies | Q42778507 | ||
| P433 | issue | 1 | |
| P304 | page(s) | 27-35 | |
| P577 | publication date | 2013-01-01 | |
| P1433 | published in | Xenotransplantation | Q15763284 |
| P1476 | title | Double knockout pigs deficient in N-glycolylneuraminic acid and galactose α-1,3-galactose reduce the humoral barrier to xenotransplantation | |
| P478 | volume | 20 |
| Q38304660 | A comparison of three methods of decellularization of pig corneas to reduce immunogenicity |
| Q34743379 | A human-specific mutation limits nonhuman primate efficacy in preclinical xenotransplantation studies |
| Q38169232 | A milestone in xenotransplantation research |
| Q26866323 | Alloantibodies to therapeutic factor VIII in hemophilia A: the role of von Willebrand factor in regulating factor VIII immunogenicity |
| Q41034751 | Anti-Neu5Gc and anti-non-Neu5Gc antibodies in healthy humans |
| Q90436304 | Application of genome-editing systems to enhance available pig resources for agriculture and biomedicine |
| Q51328345 | As2 O3 combined with leflunomide prolongs heart xenograft survival via suppressing the response of Th1, Th2, and B cells in a rat model. |
| Q39250748 | Biochemical, Cellular, Physiological, and Pathological Consequences of Human Loss of N-Glycolylneuraminic Acid. |
| Q38936714 | Biological roles of glycans |
| Q28829371 | Bioprosthetic heart valves of the future |
| Q35012361 | Bortezomib, C1-inhibitor and plasma exchange do not prolong the survival of multi-transgenic GalT-KO pig kidney xenografts in baboons |
| Q38645581 | CRISPR Editing in Biological and Biomedical Investigation. |
| Q91634406 | Carbohydrate antigen expression and anti-pig antibodies in New World capuchin monkeys: Relevance to studies of xenotransplantation |
| Q35846718 | Characterization of N-glycosylation and amino acid sequence features of immunoglobulins from swine |
| Q40545748 | Characterization of immunogenic Neu5Gc in bioprosthetic heart valves |
| Q34674815 | Cloning and expression of porcine β1,4 N-acetylgalactosaminyl transferase encoding a new xenoreactive antigen |
| Q57197910 | Commentary on “Meta-analysis of the independent and cumulative effects of multiple genetic modifications on pig lung xenograft performance during ex vivo perfusion with human blood” (by Harris et al.): tailoring donor pigs for xenotransplantation |
| Q35039006 | Comparative N-linked glycan analysis of wild-type and α1,3-galactosyltransferase gene knock-out pig fibroblasts using mass spectrometry approaches |
| Q41691103 | Creating class I MHC-null pigs using guide RNA and the Cas9 endonuclease |
| Q27027327 | Current progress of genetically engineered pig models for biomedical research |
| Q38573513 | Current status of pig kidney xenotransplantation |
| Q35613598 | Cytotoxic Effects during Knock Out of Multiple Porcine Endogenous Retrovirus (PERV) Sequences in the Pig Genome by Zinc Finger Nucleases (ZFN). |
| Q34674677 | Development of a consensus protocol to quantify primate anti-non-Gal xenoreactive antibodies using pig aortic endothelial cells |
| Q39283235 | Developmental competence of porcine genome-edited zygotes |
| Q34185181 | Double transgenic pigs with combined expression of human α1,2-fucosyltransferase and α-galactosidase designed to avoid hyperacute xenograft rejection |
| Q51058644 | Efficient generation of genetically distinct pigs in a single pregnancy using multiplexed single-guide RNA and carbohydrate selection. |
| Q37050158 | Efficient production of multi-modified pigs for xenotransplantation by 'combineering', gene stacking and gene editing |
| Q26785547 | Engineering large animal models of human disease |
| Q35197542 | Erythrocytes from GGTA1/CMAH knockout pigs: implications for xenotransfusion and testing in non-human primates |
| Q57214388 | Establishment and identification of cell lines from type O blood Korean native pigs and their efficiency in supporting embryonic development via somatic cell nuclear transfer |
| Q34043319 | Evaluation of human and non-human primate antibody binding to pig cells lacking GGTA1/CMAH/β4GalNT2 genes |
| Q38337835 | Exogenous enzymes upgrade transgenesis and genetic engineering of farm animals |
| Q38463980 | Experimental hepatocyte xenotransplantation--a comprehensive review of the literature |
| Q36843013 | Expression of NeuGc on Pig Corneas and Its Potential Significance in Pig Corneal Xenotransplantation. |
| Q39382269 | First quantification of alpha-Gal epitope in current glutaraldehyde-fixed heart valve bioprostheses. |
| Q38755069 | First update of the International Xenotransplantation Association consensus statement on conditions for undertaking clinical trials of porcine islet products in type 1 diabetes--Chapter 2b: genetically modified source pigs |
| Q38751293 | First update of the International Xenotransplantation Association consensus statement on conditions for undertaking clinical trials of porcine islet products in type 1 diabetes--Chapter 6: patient selection for pilot clinical trials of islet xenotra |
| Q41563981 | Gene Editing, Gene Therapy, and Cell Xenotransplantation: Cell Transplantation Across Species. |
| Q26768799 | Gene targeting, genome editing: from Dolly to editors |
| Q50200937 | Generation of CMAHKO/GTKO/shTNFRI-Fc/HO-1 quadruple gene modified pigs |
| Q38796503 | Generation of GGTA1 Mutant Pigs by Direct Pronuclear Microinjection of CRISPR/Cas9 Plasmid Vectors. |
| Q92204377 | Generation of cattle knockout for galactose-α1,3-galactose and N-glycolylneuraminic acid antigens |
| Q28604300 | Generation of heterozygous fibrillin-1 mutant cloned pigs from genome-edited foetal fibroblasts |
| Q36215127 | Generation of α1,3-galactosyltransferase and cytidine monophospho-N-acetylneuraminic acid hydroxylase gene double-knockout pigs |
| Q39429841 | Genetically Modified Pigs as Organ Donors for Xenotransplantation |
| Q89457423 | Genetically modified pigs as donors of cells, tissues, and organs for xenotransplantation |
| Q58764784 | Genome Editing of Pigs for Agriculture and Biomedicine |
| Q38901709 | Genome editing revolutionize the creation of genetically modified pigs for modeling human diseases |
| Q64912085 | Glycosylation in health and disease. |
| Q34018912 | Histopathologic insights into the mechanism of anti-non-Gal antibody-mediated pig cardiac xenograft rejection |
| Q53052279 | Human antibody recognition of xenogeneic antigens (NeuGc and Gal) on porcine heart valves: could genetically modified pig heart valves reduce structural valve deterioration? |
| Q30248988 | Human risk of diseases associated with red meat intake: Analysis of current theories and proposed role for metabolic incorporation of a non-human sialic acid |
| Q26746095 | Human-animal chimeras: ethical issues about farming chimeric animals bearing human organs |
| Q26826905 | Immune modulation in xenotransplantation |
| Q28081993 | Immunobiological barriers to xenotransplantation |
| Q37670770 | Immunological challenges and therapies in xenotransplantation. |
| Q64888449 | Improvement of in vitro and early in utero porcine clone development after somatic donor cells are cultured under hypoxia. |
| Q52930675 | In vitro exposure of pig neonatal isletlike cell clusters to human blood. |
| Q36097040 | Inclusion of homologous DNA in nuclease-mediated gene targeting facilitates a higher incidence of bi-allelically modified cells |
| Q36828449 | Initial in vitro studies on tissues and cells from GTKO/CD46/NeuGcKO pigs |
| Q38210098 | Islet cell xenotransplantation: a serious look toward the clinic |
| Q38240555 | Islet xenotransplantation: what is the optimal age of the islet-source pig? |
| Q26822638 | Kidney xenotransplantation |
| Q39300002 | Level of acceptance of solid organ xenotransplantation among personnel in Spanish, Mexican, and Cuban hospitals |
| Q37196570 | Long-term IgG response to porcine Neu5Gc antigens without transmission of PERV in burn patients treated with porcine skin xenografts. |
| Q38770166 | Lung xenotransplantation: a review |
| Q38231495 | Lung xenotransplantation: recent progress and current status |
| Q92617856 | Mesothelial cell transplantation: history, challenges and future directions |
| Q45329237 | Model organisms: beyond the inner circle |
| Q52424840 | Modified glycan models of pig-to-human xenotransplantation do not enhance the human-anti-pig T cell response. |
| Q38758339 | Modifying the sugar icing on the transplantation cake |
| Q34986720 | N-linked glycan profiling of GGTA1/CMAH knockout pigs identifies new potential carbohydrate xenoantigens |
| Q52356010 | OVERCOMING COAGULATION DYSREGULATION IN PIG SOLID ORGAN TRANSPLANTATION IN NONHUMAN PRIMATES: RECENT PROGRESS. |
| Q91681745 | Perspectives on the Optimal Genetically Engineered Pig in 2018 for Initial Clinical Trials of Kidney or Heart Xenotransplantation |
| Q33433973 | Pig Liver Xenotransplantation: A Review of Progress Toward the Clinic |
| Q38762314 | Pig-to-Primate Islet Xenotransplantation: Past, Present, and Future. |
| Q47136558 | Porcine to Human Heart Transplantation: Is Clinical Application Now Appropriate? |
| Q38259474 | Potential deleterious role of anti-Neu5Gc antibodies in xenotransplantation |
| Q37058688 | Pre-transplant antibody screening and anti-CD154 costimulation blockade promote long-term xenograft survival in a pig-to-primate kidney transplant model. |
| Q33694819 | Production of CMAH Knockout Preimplantation Embryos Derived From Immortalized Porcine Cells Via TALE Nucleases |
| Q33885425 | Production of Mutated Porcine Embryos Using Zinc Finger Nucleases and a Reporter-based Cell Enrichment System |
| Q33805449 | Production of biallelic CMP-Neu5Ac hydroxylase knock-out pigs |
| Q37657528 | Production of α1,3-galactosyltransferase and cytidine monophosphate-N-acetylneuraminic acid hydroxylase gene double-deficient pigs by CRISPR/Cas9 and handmade cloning |
| Q38916037 | Progress in Clinical Encapsulated Islet Xenotransplantation |
| Q34250530 | Progress in pig-to-non-human primate transplantation models (1998-2013): a comprehensive review of the literature |
| Q42569417 | Recent advances in understanding xenotransplantation: implications for the clinic |
| Q34041201 | Reduced binding of human antibodies to cells from GGTA1/CMAH KO pigs |
| Q26769878 | Report from IPITA-TTS Opinion Leaders Meeting on the Future of β-Cell Replacement |
| Q33430240 | Silencing Porcine CMAH and GGTA1 Genes Significantly Reduces Xenogeneic Consumption of Human Platelets by Porcine Livers |
| Q38878173 | Silencing porcine genes significantly reduces human-anti-pig cytotoxicity profiles: an alternative to direct complement regulation |
| Q39828679 | Silencing the porcine iGb3s gene does not affect Galα3Gal levels or measures of anticipated pig-to-human and pig-to-primate acute rejection |
| Q88228692 | Skin xenotransplantation: Historical review and clinical potential |
| Q38245175 | The International Xenotransplantation Association consensus statement on conditions for undertaking clinical trials of xenocorneal transplantation. |
| Q94464392 | The Possible Role of Anti-Neu5Gc as an Obstacle in Xenotransplantation |
| Q44021296 | The alpha1,3GalT knockout/alpha1,2FucT transgenic pig does not appear to have an advantage over the alpha1,3GalT knockout pig with respect to glycolipid reactivity with human serum antibodies |
| Q39761921 | The case for xenotransplantation |
| Q35547701 | The current state of xenotransplantation |
| Q38588520 | The immunological barriers to xenotransplantation |
| Q48088290 | The impact of serum incubation time on IgM/IgG binding to porcine aortic endothelial cells |
| Q38712532 | The pathobiology of pig-to-primate xenotransplantation: a historical review |
| Q34037598 | The potential of genetically-engineered pigs in providing an alternative source of organs and cells for transplantation |
| Q34044894 | The role of genetically engineered pigs in xenotransplantation research |
| Q46277949 | The role of sialic acids in the immune recognition of xenografts |
| Q49370485 | Use of gene-editing technology to introduce targeted modifications in pigs |
| Q26771395 | Use of genetically-engineered pig donors in islet transplantation |
| Q90496748 | Xenoantigen Deletion and Chemical Immunosuppression Can Prolong Renal Xenograft Survival |
| Q38095671 | Xenotransplantation literature update, January-February 2013. |
| Q47261347 | Xenotransplantation-the current status and prospects. |
| Q89621137 | Xenotransplantation: Current Status in Preclinical Research |
| Q47279794 | Xenotransplantation: back to the future? |
Search more.